There are many challenges that come with a diagnosis of metastatic breast cancer (mBC) – breast cancer that has spread to other parts of the body. There’s shock and anxiety. There’s tremendous uncertainty. For a lot of patients, there’s the need to continue working and caring for their families. And there are misperceptions that create isolation.
With the goal of easing some of these burdens, Pfizer is issuing a call for technology innovations. Over the course of the challenge, we’ll award a total of $250,000 in prize funding for tech-enabled solutions with the potential to enrich the lives of patients with mBC.
We’re calling on all innovators to learn more and apply.
This article was originally published at the “Article” source noted above and distributed by The Tutu Project for informational purposes only.